A global pharmaceutical company with a major UK presence. Through innovation and collaboration we can achieve better health for all.
MedImmune is the worldwide biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines.
MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines
AstraZeneca's focus is on developing new medicines that make a meaningful difference to patients’ lives, and the UK is right at the heart of efforts to do that.
AstraZeneca is a major contributor to UK science and innovation investment, economic prosperity and to patient health.